Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525745 · ClinicalTrials.gov registry record · Phase 2
Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT01525745 is a Phase 2 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 6 participants.
The verdict
NCT01525745, a Phase 2 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how effective SBRT is compared to traditional radiation in treating the cancer that has spread to your spine and is causing pain. SBRT is delivered at a higher dose for a shorter period of time when compared to standard radiation therapy and the aim is to see if there will be an improvement both in pain control and your cancer It is not known whether SBRT is better or worse than current standard therapy. If you are selected to receive the experimental treatment in this research study, SBRT uses highly focused x-rays that deliver a single high dose to a specific area of the spine compared to conventional standard radiation over a period of 10 days which has been the standard proven treatment to help your condition. The investigators will also determine which treatment provides the most rapid pain relief with the least side effects. It is possible that SBRT may not be better or could be more toxic. The investigators will conduct quality of life assessments and pain scale index to assess how you are feeling once you have had the intervention.
Interventions
- RADIATION External Beam Radiation Therapy
- RADIATION Radiosurgery/SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01525745
The ClinicalTrials.gov registry entry for NCT01525745 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which External Beam Radiation Therapy is the first listed.
NCT01525745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01525745 about?
NCT01525745 is a clinical study titled "Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis". The purpose of this study is to determine how effective SBRT is compared to traditional radiation in treating the cancer that has spread to your spine and is causing pain. SBRT is delivered at a higher dose for a shorter period of time when compared to standard radiation therapy and the aim is to se...
What is the current status of trial NCT01525745?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2012-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01525745?
The interventions under investigation include: External Beam Radiation Therapy (RADIATION), Radiosurgery/SBRT (RADIATION).
Who is sponsoring clinical trial NCT01525745?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.